Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma

The combination of lenalidomide and dexamethasone (Len–Dex) is a commonly used initial therapy for newly diagnosed multiple myeloma (MM). Although the initial response rates and toxicity are well known, long-term outcome is not well described. We studied 286 consecutive patients with newly diagnosed...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Srivastava, G, Rana, V, Lacy, MQ, Buadi, FK, Hayman, SR, Dispenzieri, A, Gertz, MA, Dingli, D, Zeldenrust, S, Russell, S, McCurdy, A, Kapoor, P, Kyle, R, Rajkumar, SV, Kumar, S
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3795989/
https://ncbi.nlm.nih.gov/pubmed/23648667
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2013.143
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados